- Home
- PMTS vs BNTC Comparison
PMTS vs BNTC Comparison
Compare PMTS & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMTS | BNTC |
|---|---|---|
| Founded | 2007 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 183.1M | 405.7M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | PMTS | BNTC |
|---|---|---|
| Price | $13.58 | $12.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $32.00 | $27.67 |
| AVG Volume (30 Days) | 37.1K | ★ 208.9K |
| Earning Date | 03-03-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.20 | N/A |
| Revenue | ★ $515,576,000.00 | N/A |
| Revenue This Year | $13.70 | N/A |
| Revenue Next Year | $8.51 | N/A |
| P/E Ratio | $11.38 | ★ N/A |
| Revenue Growth | ★ 12.48 | N/A |
| 52 Week Low | $11.64 | $9.70 |
| 52 Week High | $34.25 | $17.15 |
Technical Indicators
Market Signals| Indicator | PMTS | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 34.92 | 47.11 |
| Support Level | $13.20 | $11.40 |
| Resistance Level | $14.83 | $12.55 |
| Average True Range (ATR) | 0.54 | 0.90 |
| MACD | -0.20 | -0.02 |
| Stochastic Oscillator | 16.11 | 34.28 |
Price Performance
Historical ComparisonAbout PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.